BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 38053460)

  • 21. Incidence and Prevalence of Cardiovascular Risk Factors Among Patients With Rheumatoid Arthritis, Psoriasis, or Psoriatic Arthritis.
    Radner H; Lesperance T; Accortt NA; Solomon DH
    Arthritis Care Res (Hoboken); 2017 Oct; 69(10):1510-1518. PubMed ID: 27998029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study.
    Lee JL; Sinnathurai P; Buchbinder R; Hill C; Lassere M; March L
    Arthritis Res Ther; 2018 Aug; 20(1):171. PubMed ID: 30086795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).
    Ramiro S; Radner H; van der Heijde D; van Tubergen A; Buchbinder R; Aletaha D; Landewé RB
    Cochrane Database Syst Rev; 2011 Oct; (10):CD008886. PubMed ID: 21975788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular Event Risk in Rheumatoid Arthritis Compared with Type 2 Diabetes: A 15-year Longitudinal Study.
    Agca R; Hopman LHGA; Laan KJC; van Halm VP; Peters MJL; Smulders YM; Dekker JM; Nijpels G; Stehouwer CDA; Voskuyl AE; Boers M; Lems WF; Nurmohamed MT
    J Rheumatol; 2020 Mar; 47(3):316-324. PubMed ID: 31092721
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of pre-eclampsia and impact of disease activity and antirheumatic treatment in women with rheumatoid arthritis, axial spondylarthritis and psoriatic arthritis: a collaborative matched cohort study from Sweden and Denmark.
    Secher AEP; Granath F; Glintborg B; Rom A; Hetland ML; Hellgren K
    RMD Open; 2022 Nov; 8(2):. PubMed ID: 36328400
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of cardiovascular comorbidities before and after the onset of rheumatic diseases.
    Aaramaa HK; Mars N; Helminen M; Kerola AM; Palomäki A; Eklund KK; Gracia-Tabuenca J; Sinisalo J; FinnGen ; Isomäki P
    Semin Arthritis Rheum; 2024 Apr; 65():152382. PubMed ID: 38308930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis.
    Peters MJ; Symmons DP; McCarey D; Dijkmans BA; Nicola P; Kvien TK; McInnes IB; Haentzschel H; Gonzalez-Gay MA; Provan S; Semb A; Sidiropoulos P; Kitas G; Smulders YM; Soubrier M; Szekanecz Z; Sattar N; Nurmohamed MT
    Ann Rheum Dis; 2010 Feb; 69(2):325-31. PubMed ID: 19773290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subsequent Cardiovascular Events Among Patients With Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis: Patterns of Disease-Modifying Antirheumatic Drug Treatment.
    Sparks JA; Lesperance T; Accortt NA; Solomon DH
    Arthritis Care Res (Hoboken); 2019 Apr; 71(4):512-520. PubMed ID: 29799667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Factors associated with long-term retention of treatment with golimumab in rheumatoid arthritis, axial spondyloarthritis, and psoriatic arthritis: an analysis of the Spanish BIOBADASER registry.
    Pombo-Suarez M; Sanchez-Piedra C; Garcia-Magallón B; Pérez-Gómez A; Manrique-Arija S; Martín-Doménech R; Colazo M; Campos C; Campos J; Del Pino-Montes J; Arteaga MJ; Cea-Calvo L; Díaz-González F; Gómez-Reino JJ
    Clin Rheumatol; 2021 Oct; 40(10):3979-3988. PubMed ID: 33907904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extent of axial damage in psoriatic arthritis and spondyloarthritis: comparative data from the BEPAS and (Be-)GIANT multicentre cohorts.
    de Hooge M; Ishchenko A; De Craemer AS; Steinfeld S; Nzeusseu A; Elewaut D; Lories R; de Vlam K; Van den Bosch F
    RMD Open; 2023 May; 9(2):. PubMed ID: 37137541
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review.
    Horreau C; Pouplard C; Brenaut E; Barnetche T; Misery L; Cribier B; Jullien D; Aractingi S; Aubin F; Joly P; Le Maître M; Ortonne JP; Paul C; Richard MA
    J Eur Acad Dermatol Venereol; 2013 Aug; 27 Suppl 3():12-29. PubMed ID: 23845149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prediction of cardiovascular events in patients with ankylosing spondylitis and psoriatic arthritis: role of lipoproteins in a high-risk population.
    Semb AG; Kvien TK; DeMicco DA; Fayyad R; Wun CC; LaRosa J; Betteridge J; Pedersen TR; Holme I
    J Rheumatol; 2012 Jul; 39(7):1433-40. PubMed ID: 22660802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prevalence and impact of comorbid fibromyalgia in inflammatory arthritis.
    Zhao SS; Duffield SJ; Goodson NJ
    Best Pract Res Clin Rheumatol; 2019 Jun; 33(3):101423. PubMed ID: 31703796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vitamin D deficiency in chronic inflammatory rheumatic diseases: results of the cardiovascular in rheumatology [CARMA] study.
    Urruticoechea-Arana A; Martín-Martínez MA; Castañeda S; Piedra CA; González-Juanatey C; Llorca J; Díaz-Gonzalez F; González-Gay MA;
    Arthritis Res Ther; 2015 Aug; 17(1):211. PubMed ID: 26271333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk Factors for Diagnosis of Psoriatic Arthritis, Psoriasis, Rheumatoid Arthritis, and Ankylosing Spondylitis: A Set of Parallel Case-control Studies.
    Meer E; Thrastardottir T; Wang X; Dubreuil M; Chen Y; Gelfand JM; Love TJ; Ogdie A
    J Rheumatol; 2022 Jan; 49(1):53-59. PubMed ID: 34334358
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incident myocardial infarction associated with major types of arthritis in the general population: a systematic review and meta-analysis.
    Schieir O; Tosevski C; Glazier RH; Hogg-Johnson S; Badley EM
    Ann Rheum Dis; 2017 Aug; 76(8):1396-1404. PubMed ID: 28219882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular disease and rheumatoid arthritis: an update.
    Charles-Schoeman C
    Curr Rheumatol Rep; 2012 Oct; 14(5):455-62. PubMed ID: 22791398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
    Han C; Robinson DW; Hackett MV; Paramore LC; Fraeman KH; Bala MV
    J Rheumatol; 2006 Nov; 33(11):2167-72. PubMed ID: 16981296
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity.
    Solomon DH; Kremer J; Curtis JR; Hochberg MC; Reed G; Tsao P; Farkouh ME; Setoguchi S; Greenberg JD
    Ann Rheum Dis; 2010 Nov; 69(11):1920-5. PubMed ID: 20444756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of Incident Liver Disease in Patients with Psoriasis, Psoriatic Arthritis, and Rheumatoid Arthritis: A Population-Based Study.
    Ogdie A; Grewal SK; Noe MH; Shin DB; Takeshita J; Chiesa Fuxench ZC; Carr RM; Gelfand JM
    J Invest Dermatol; 2018 Apr; 138(4):760-767. PubMed ID: 29104161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.